Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

PPD acquires Acurian to strengthen patient recruitment and retention services

PPD : 28 August, 2013  (Company News)
Pharmaceutical Product Development (PPD) acquires Acurian, a leading full-service provider of clinical trial patient enrollment and retention solutions for the life sciences industry.


"As the biopharmaceutical industry continues to face increasing challenges with the time and cost of drug development, PPD is committed to bringing innovation to the clinical development process to deliver efficiencies for our customers," David Simmons, Chairman and Chief Executive Officer of PPD, said. "Acurian's best-in-class approach to patient recruitment will be an excellent complement to PPD's clinical development expertise. Acurian will enable PPD to provide clients industry-leading services that accelerate patient enrollment and support their strategies for data-driven feasibility, site selection and enrollment delivery."



Providing analytics-driven services to many large- and mid-sized pharmaceutical companies, Acurian manages the entire patient recruitment cycle, from recruitment to enrollment to retention. These services utilise innovative, proprietary and highly predictive software analytics to customise the most efficient and cost-effective approach to recruiting patients for a customer's clinical trial.



Acurian will continue to operate under its own name as a separate business unit with its existing management team led by Rick Malcolm, who has served as Acurian's Chief Executive Officer since 2005.



"We are excited about the opportunity to become part of a leading global contract research organization," Malcolm said. "Combining Acurian's 15 years of experience in successfully innovating to meet the challenges of patient enrollment and retention with PPD's full spectrum of drug development services will enable us to merge the expertise of both organizations and offer clients unique solutions for clinical trial feasibility studies and patient recruitment and retention."



Based in Horsham, Pennsylvania, Acurian provides services globally.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo